Phytochemistry, Bioactivity, and Toxicological Duality of Oxytropis glabra DC: A Review
Molecules · 2025
DOI: 10.3390/molecules31010044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Karlygash Raganina und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan. Hauptthemen laut MEDLINE: Oxytropis, Plant Extracts, Phytochemicals. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oxytropis glabra DC, a Fabaceae species distributed across Central Asia, is characterized by a dual biological profile encompassing pronounced toxicity alongside promising pharmacological potential. This review synthesizes current knowledge on its phytochemistry, bioactivity, and toxicological liabilities to clarify the plant’s risk–benefit landscape. The objectives are to summarize the dominant classes of metabolites identified in O. glabra, evaluate their toxicological and therapeutic relevance, and identify key gaps limiting translational research. O. glabra contains a diverse array of secondary metabolites, with quinolizidine and indolizidine alkaloids, including swainsonine, anagyrine, thermopsine, and sparteine, representing the primary determinants of toxicity. These compounds are associated with teratogenicity, neurotoxicity, and locoism through mechanisms involving α-mannosidase inhibition, disruption of glycoprotein processing, and impaired lysosomal homeostasis. In contrast, flavonoids such as quercetin, isoquercitrin, and kaempferol derivatives exhibit antioxidant, anti-inflammatory, hepatoprotective, and cardioprotective effects, while triterpenoid saponins and fatty acids contribute additional cytoprotective and metabolic activities. Despite extensive reports on both toxic and bioactive constituents, critical gaps remain regarding chemotype variability, dose–response relationships, and pharmacokinetics, which currently constrain therapeutic exploitation. Future research should prioritize defining safe exposure thresholds, elucidating structure–activity relationships, and developing standardized extracts or optimized derivatives that balance efficacy and safety. This integrative perspective highlights O. glabra as a chemically rich but biologically ambivalent species whose toxicological risks and pharmacological opportunities warrant systematic mechanistic investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan.
- Department of Pharmaceutical Disciplines, Astana Medical University, Astana 010000, Kazakhstan.
- Department of Pharmaceutical Disciplines, Marat Ospanov West Kazakhstan Medical University, Maresyev 68, Aktobe 030019, Kazakhstan.
- Higher School of Medicine, Al-Farabi Kazakh National University, Tole-bi 96, Almaty 050040, Kazakhstan.
- Department of Pharmaceutical and Toxicological Chemistry, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan.
- Department of Chemistry and Technology of Organic Substances, Natural Compounds and Polymers, Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
ORCID-Profile: Karlygash Raganina, Meruyert Amantayeva, Aigul Kaldybayeva, Yerbol Ikhsanov, Zhanserik Shynykul, Moldir Koilybayeva
Zitieren
APA
Raganina, K., Amirkhanova, A., Akhelova, S., Berdgaleyeva, A., Amantayeva, M., Kartbayeva, E., Kaldybayeva, A., Nurlybayev, M., Ikhsanov, Y., Iztileu, N., Shynykul, Z., & Koilybayeva, M. (2025). Phytochemistry, Bioactivity, and Toxicological Duality of Oxytropis glabra DC: A Review. Molecules. https://doi.org/10.3390/molecules31010044
Vancouver
Raganina K, Amirkhanova A, Akhelova S, Berdgaleyeva A, Amantayeva M, Kartbayeva E, et al. Phytochemistry, Bioactivity, and Toxicological Duality of Oxytropis glabra DC: A Review. Molecules. 2025. doi:10.3390/molecules31010044
BibTeX
@article{Raganina2025,
author = {Raganina, Karlygash and Amirkhanova, Akerke and Akhelova, Sholpan and Berdgaleyeva, Aiman and Amantayeva, Meruyert and Kartbayeva, Elmira and Kaldybayeva, Aigul and Nurlybayev, Madi and Ikhsanov, Yerbol and Iztileu, Nurzhan and Shynykul, Zhanserik and Koilybayeva, Moldir},
title = {Phytochemistry, Bioactivity, and Toxicological Duality of Oxytropis glabra DC: A Review},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules31010044}
}
EUVIMED